# Patient-derived outcome assessment of knowledge, communication, and management in those diagnosed with BAP1-tumor predisposition syndrome

**Authors:** Kelley Godwin, Joseph McElroy, Leigha Senter, Lindsey Byrne, Mohamed H. Abdel-Rahman

PMC · DOI: 10.1007/s10689-026-00541-8 · Familial Cancer · 2026-03-17

## TL;DR

This study surveyed patients with BAP1 tumor predisposition syndrome to assess their knowledge, communication with family, and adherence to cancer surveillance guidelines.

## Contribution

The study provides patient-reported insights into knowledge, communication, and management practices in BAP1 tumor predisposition syndrome.

## Key findings

- Most participants (60%) had strong knowledge of BAP1-TPDS, and 79% had at least moderate knowledge.
- All participants shared their diagnosis with at least one family member, mostly first-degree relatives.
- Most participants followed some recommended cancer surveillance measures for BAP1-TPDS.

## Abstract

Germline pathogenic variants in BAP1 are associated with BAP1 tumor predisposition syndrome (BAP1-TPDS), and an increased risk for different cancers and preneoplastic lesions. This study assessed the degrees of patient knowledge of BAP1-TPDS, patient-reported sharing of their genetic test results and diagnosis, and the degree of compliance with current management guidelines. A survey was sent to individuals with a germline pathogenic/likely pathogenic variant in BAP1 who are enrolled in a research registry at The Ohio State University. Knowledge about BAP1-TPDS was assessed utilizing a modified scale (KnowGene). Participants were asked about communication surrounding BAP1-TPDS with family members, and their current cancer surveillance. Forty-two (55%) subjects completed the survey with 25 (60%) having strong 80% knowledge of the syndrome, and 33 (79%) having at least 60% knowledge. All participants reported sharing their genetic result or diagnosis with at least one family member, primarily their first-degree relatives. Most of the cohort had undergone some recommended surveillance for BAP1-TPDS. In conclusion, BAP1-TPDS subjects are knowledgeable about the syndrome phenotype, highly communicative about their diagnosis with family members, and follow some recommended surveillance. Capturing patient-reported outcomes of BAP1-TPDS subjects is crucial for understanding their need for further education, resources, or support.

The online version contains supplementary material available at 10.1007/s10689-026-00541-8.

## Linked entities

- **Genes:** BAP1 (BRCA1 associated deubiquitinase 1) [NCBI Gene 8314]
- **Diseases:** BAP1 tumor predisposition syndrome (MONDO:0013692)

## Full-text entities

- **Genes:** BAP1 (BRCA1 associated deubiquitinase 1) [NCBI Gene 8314] {aka HUCEP-13, KURIS, TPDS1, UBM2, UCHL2, UVM2}
- **Diseases:** RCC (MESH:D002292), breast cancer (MESH:D001943), Hereditary Predisposition Syndrome (MESH:D009386), BIMTs (OMIM:604370), UM (MESH:C536494), preneoplastic lesions (MESH:D011230), ovarian cancer (MESH:D010051), mesothelioma (MESH:D008654), melanoma (MESH:D008545), tumor predisposition syndrome (OMIM:614327), meningioma (MESH:D008579), CM (MESH:C562393), Cancer (MESH:D009369), MMe (MESH:D000086002), hepatocellular carcinoma (MESH:D006528), Lynch syndrome (MESH:D003123), inactivated (MESH:C572568), kidney cancer (MESH:D007680), HBOC (MESH:D061325), BCC (MESH:D002280), eye cancer (MESH:D005134), cholangiocarcinoma (MESH:D018281), P (MESH:D002972), skin cancer (MESH:D012878)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996006/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12996006/full.md

---
Source: https://tomesphere.com/paper/PMC12996006